The Motley Fool··Eric VolkmanMannKind Shares Drop Despite Revenue Beat as Profitability Pressures Emerge
MannKind beat revenue expectations with 46% growth, but stock fell 7% due to disappointing earnings and elevated operational costs from acquisition integration.
MNKDstock declinebiotech earnings